Table 1 Demographic parameters and baseline data
Demographics | No VR (n = 56) | VR (n = 60) | Total (n = 116) |
|---|---|---|---|
Age in years ± SDa | 63 ± 12 | 62 ± 13.6 | 62 ± 12.6 |
Gender | |||
Male | 43 (76.8%) | 35 (58.3%) | 78 (67.2%) |
Female | 13 (23.2%) | 25 (41.7%) | 38 (32.8%) |
BMI in kg/m2 ± SD | 25.3 ± 5.5 | 25.7 ± 6.1 | 25.5 ± 5.8 |
ASAb category | |||
I | 1 (1.8%) | 0 (0%) | 1 (0.9%) |
II | 15 (26.8%) | 11 (18.3%) | 26 (22.4%) |
III | 40 (71.4%) | 49 (81.7%) | 89 (76.7%) |
Previous port implantations | 7 (12.5%) | 6 (10%) | 13 (11.2%) |
Disease | |||
Pancreatic carcinoma | 10 (16.7%) | 9 (15.0%) | 19 (16.4%) |
Esophageal carcinoma | 8 (13.3%) | 7 (11.7%) | 15 (12.9%) |
Gastric carcinoma | 6 (10.0%) | 4 (6.7%) | 10 (8.6%) |
Colorectal carcinoma | 14 (23.3%) | 12 (20.0%) | 26 (22.4%) |
Hepatocellular carcinoma | 1 (1.7%) | 1 (1.7%) | 2 (1.7%) |
Cholangiocellular carcinoma | 2 (3.3%) | 3 (5.0%) | 5 (4.3%) |
Other | 15 (25.0%) | 24 (40.0%) | 39 (33.6%) |
Charlson Comorbidity Index | 3.2 ± 1.8 | 3.2 ± 1.8 | 3.2 ± 1.8 |
Implantation technique | |||
Venae section of cephalic vein | 50 (89.3%) | 52 (86.7%) | 102 (87.9%) |
Puncture of subclavian vein | 4 (7.1%) | 6 (10.0%) | 10 (8.6%) |
Puncture of internal jugular vein | 1 (1.8%) | 1 (1.7%) | 2 (1.7%) |